Measles Vaccine: Is There a Protective Role in COVID 19 Pandemic?
1 other identifier
observational
60
1 country
1
Brief Summary
The following two mechanisms that explain the ability of measles vaccine to cause partial protection against COVID-19. The first is that measles vaccine may increase the ability of the immune system to fight off pathogens other than measles due to the generated bystander immunity that would enhance the overall immunity against the new coronavirus. The second is that SARS-CoV-2 is proven to have structure similarities with measles, which may cause cross-reactivity and immunity between measles vaccines and COVID-19, leading to partial protection against COVID-19 in vaccinated subjects
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jul 2020
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 23, 2020
CompletedFirst Posted
Study publicly available on registry
June 24, 2020
CompletedStudy Start
First participant enrolled
July 1, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2020
CompletedJune 26, 2020
June 1, 2020
2 months
June 23, 2020
June 24, 2020
Conditions
Outcome Measures
Primary Outcomes (1)
Viral clearance
Achievement of two consecutive negative PCR results for COVID 19 and discharge from hospital
6 months
Study Arms (3)
A
mild
B
moderate
C
severe
Eligibility Criteria
all patients with confirmed COVID-19 presented to Ain Shams Hospital
You may qualify if:
- All patients with confirmed COVID 19.
- Any age or gender
You may not qualify if:
- \- Any patient refusing to be involved in the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Faculty of Medicine Ain Shams University Research Institute- Clinical Research Center
Cairo, Non-US, 11566, Egypt
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Amira Al Balakosy, M.D
Ain Shams University
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Tropical Medicine Department. Ain Shams University
Study Record Dates
First Submitted
June 23, 2020
First Posted
June 24, 2020
Study Start
July 1, 2020
Primary Completion
September 1, 2020
Study Completion
November 1, 2020
Last Updated
June 26, 2020
Record last verified: 2020-06
Data Sharing
- IPD Sharing
- Will not share